Nanotech

Nanotechnology applied in health

What we do

We use nanotechnology to develop processes for stability and improvement of product bioavailability

Nanotech Division

We are partners of Nanomed, a company with more than a decade of expertise in nanotechnology processes, working for the national and international pharmaceutical industry, and we also develop proprietary technologies in order to improve the performance and delivery of our probiotics, developing what we have called new generation probiotics, or bio-intelligent, because they are released gradually and in specific places, increasing their efficiency and controlling their effect.

Our latest nanotechnology processes applied to special pool of MOs ensure long-term stability and enable bioavailability during storage outside refrigeration. This proprietary biotechnology, maintained as an industrial secret, has the potential to transform global probiotic distribution, particularly in regions where cold chain storage is challenging.

Services provide by partnership with UTA Innovation and commercialization Department's

Innovation and safety

Stability Tests
Accelerated stability test
Real-time stability Viability of strains over time
Microencapsulation integrity analysis
Targeted release evaluation (target delivery)
Microbiological and Purity Tests Absence of pathogens
Total count of microorganisms and fungi
Bacterial endotoxin test (LAL)
Molecular identification of specific strains (qPCR)
Physical-Chemical and Technological Tests
Residual moisture content
pH analysis of the formulation
Solubility and dispersion
Particle size and uniformity
Thermal analysis (DSC/TGA)
Functional Tests
In vitro simulation of the gastrointestinal tract
Intestinal epithelial cell adhesion tests
Post-release metabolization studies
Security Tests
Cytotoxicity test
Genotoxicity test (Ames Test)
Irritation and sensitization test
Preclinical evaluation of adverse reactions